Genetic Cell Surface Glycoengineering Service

Genetic Cell Surface Glycoengineering Service

Genetic Cell Surface Glycoengineering Service at CD BioGlyco

Gene cell surface sugar engineering service is a biotechnology service that aims to achieve precise control of cell characteristics by changing the sugar structure on the cell surface. Carbohydrate structures play key roles in many biological processes, including cell signaling, immune recognition, disease development, and more. Through gene editing and engineering techniques, researchers can tweak these structures to explore different cell behaviors. Engineered cells with modified glycan structures can be used in a wide range of applications, including immunotherapy, cancer research, drug development, and regenerative medicine.

Fig.1 Overview of principles and strategies for stable genetic engineering of cellular glycosylation capacities. (Narimatsu, et al., 2021)Fig.1 Overview of principles and strategies for stable genetic engineering of cellular glycosylation capacities. (Narimatsu, et al., 2021)

CD BioGlyco provides systematic overall solutions for Cell Surface Glycoengineering. Our Technologies for Cell Surface Glycoengineering are performed by experts with many years of experience in this field. We provide clients with professional genetic cell surface sugar engineering services. The technology involves a series of molecular biology and genetic engineering techniques to modify the glycan structure on the cell surface. Our genetic cell surface sugar engineering services include but are not limited to:

  • Gene selection: This process begins with the selection of specific genes involved in glycan biosynthesis or modification. These genes may encode glycosyltransferases, glycosidases, or other enzymes and proteins that affect glycan structure.
  • Genetic modification: Genetic modification of selected genes using technologies such as CRISPR/Cas9, or TALEN. These modifications include gene knockout, overexpression, or precise editing to alter the activity of the encoded protein.
  • Cell line selection: Engineered genes are introduced into specific cell lines. Cell line selection depends on the research or application and includes various types of mammalian cells, stem cells, or immune cells.
  • Cell culture: Modified cells are cultured under controlled conditions to allow the expression of engineered genes and subsequent glycan modification.
  • Analysis and characterization: Characterization of altered glycan structures on the cell surface using a variety of analytical techniques such as mass spectrometry, lectin binding assays, and flow cytometry.
  • Functional studies: To assess the functional impact of modified glycan structures, and perform cell adhesion assays, signal transduction studies, or immune response assays.

Gene Knockout-based Cell Surface Glycoengineering Service

CD BioGlyco is dedicated to maintaining the highest standards and ensuring client satisfaction in the realm of gene knockout-based cell surface glycoengineering.

Gene Overexpression-based Cell Surface Glycoengineering Service

CD BioGlyco is dedicated to assisting clients in achieving success in the research of gene overexpression-based cell surface glycoengineering.

Applications

  • Immunotherapeutics enhancement: Genetic cell surface glycoengineering can be applied to boost the efficacy of immunotherapies by modifying cell surface glycan structures, potentially enhancing immune recognition and response against cancer cells.
  • Vaccine development: Genetic cell surface glycoengineering plays a vital role in vaccine development by engineering cell surfaces to express specific glycoproteins, enabling the production of viral vectors for vaccine candidates.
  • Stem cell engineering: Genetic cell surface glycoengineering facilitates the creation of customized stem cells with altered glycosylation patterns, opening avenues for regenerative medicine, tissue engineering, and disease modeling.
  • Drug target validation: Researchers employ this technology to validate the role of specific glycoproteins in disease mechanisms, aiding in the identification of potential drug targets and therapeutic strategies.

Advantages

  • Our company has a team of experts in genetic cell surface glycoengineering, with extensive experience in manipulating glycan structures on the cell surface.
  • We have established a high-quality Glycoengineering Platform.
  • We employ the latest techniques and tools in genetic engineering to modify cell surface glycans with precision, ensuring the highest quality results.
  • From project design to data analysis, we provide end-to-end support. Our team assists you at every stage of your research, ensuring you achieve your goals efficiently.

At CD BioGlyco, our commitment to excellence is evident in every aspect of the genetic cell surface glycoengineering service. If you are interested in our services, please do not hesitate to contact us for more details.

Reference

  1. Narimatsu, Y.; et al. Genetic glycoengineering in mammalian cells. Journal of Biological Chemistry. 2021, 296.
This service is for Research Use Only, not intended for any clinical use.

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.